VC firms
We are aware about the complexity of the technology transfer process in LATAM, resulting in a very low existence and creation of sucesful science based companies. We focus on creating a bridge, a new technology transfer process that will lead to the creation of high impact, global, disruptive and sustainable companies that will change the world. WE ARE THE FIRST SCIENCE BASED COMPANY BUILDER IN LATIN AMERICA
Overview
Location
Argentina, Autonomous City of Buenos Aires, Buenos Aires
Employees
1-10
Investment Type
Venture Capital; Accelerator
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 28, 2025 | GRIDX: Interview With Co-Founder Matias Peire About The Life Sciences VC Firm | GRIDX is the leading venture capital fund for life sciences companies in Latin America. Pulse 2.0 interviewed GRIDX founder and CEO Matias Peire to learn more about the firm. Matias Peire’s Background What is Matias Peire’s background? Peir... |
| Apr 21, 2025 | GridX Connects U.S. Biotech Investors with Latin America’s Untapped Innovation Potential | BUENOS AIRES–(BUSINESS WIRE)–April 21, 2025– GridX, Latin America’s largest biotechnology investment fund and company builder, is set to begin its international Roadshow featuring 21 innovative startups across three strategic U.S. cities, b... |
| Jul 8, 2024 | ByBug: Black soldier flies can deliver cheaper, more scalable recombinant protein production | Chilean startup ByBug has raised a $1.4 million seed round as it builds a platform to produce recombinant proteins from genetically engineered black soldier flies, an approach it claims is cheaper and more scalable than using engineered mic... |
| Jul 18, 2023 | Q&A: GRIDX CEO on why Argentina is leading Latin America’s boom in biotech innovation | Argentina, Latin America’s southernmost country, is often characterized by ongoing economic crises and turmoil. But it is also fast becoming an innovation center for biotech: Second only to the US, Argentina is now the main provider of proj... |
| Apr 18, 2023 | Танго для приезжих: какие возможности иностранцам дает Аргентина | Содержание: Деловой климат Как начать бизнес Плюсы и минусы Акселераторы и фонды Популярные ниши для стартапов Виза, ВНЖ и гражданство в Аргентине Мифы и особенности Бизнес-сообщества и мероприятия Резюме Население Аргентины, по данным госу... |
| Sep 1, 2022 | BREAKING: Biologicals startup Puna Bio lands $3.7m to fight climate change with ‘extreme bacteria’ | Argentina’s Puna Bio has raised $3.7 million for its seed treatment that leverages the power of extremophiles — living microorganisms able to develop and survive in extreme conditions — to strengthen crops against the impacts of climate cha... |
| Mar 1, 2022 | Stämm Biotech raises $17M to develop desktop 3D printed bioreactor | Argentinian biotechnology firm Stämm Biotech has reportedly closed a $17 million Series A funding round which will help the company accelerate the development of its next-generation 3D printed bioreactor. The firm is developing its microflu... |
| Aug 15, 2019 | How Argentina’s GridX is building foodtech and agtech companies with backing from billionaires | It took Matias Peire three years to decide what to do after exiting the video monitoring and processing business he’d created for the broadcast industry. He knew he wanted to make a difference and was tempted by venture capital. But after d... |
Reviews 0
FAQ about Grid Exponential
What has the press written about Grid Exponential?
Parsers VC has collected 9 articles mentioning Grid Exponential, among them “GRIDX: Interview With Co-Founder Matias Peire About The Life Sciences VC Firm” (Apr 28, 2025) and “GridX Connects U.S. Biotech Investors with Latin America’s Untapped Innovation Potential” (Apr 21, 2025).
Is Grid Exponential still active?
Yes, Grid Exponential is active; its latest activity on Parsers VC dates from Sep 8, 2025.